Free tool
FAERS Monitor: Zurzuvae
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 217369 or its brand name (Zurzuvae, Zuranolone). Reports on generic versions are filed under their own applications.
Reports
1,940
Serious
306
16% of reports
Hospitalization
101
Death reported
19
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- somnolence637
- dizziness368
- fatigue299
- anxiety151
- sedation150
- feeling abnormal139
- suicidal ideation112
- tremor106
- feeling drunk91
- depression86
- nausea79
- memory impairment74
- drug ineffective73
- gait disturbance73
- insomnia69
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2023 | 1 |
| 2024 | 379 |
| 2025 | 753 |
| 2026 | 807 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,219 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| feeling drunkSignal | 91 | 134.4 | 109.8 | 11,775 |
| sedationSignal | 150 | 62.4 | 53.5 | 8,968 |
| somnolenceSignal | 637 | 34.4 | 32.3 | 20,760 |
| suicidal ideationSignal | 112 | 13.3 | 11.1 | 1,263 |
| dizzinessSignal | 368 | 8.0 | 7.3 | 2,301 |
| tremorSignal | 106 | 6.9 | 5.8 | 536 |
| feeling abnormalSignal | 139 | 6.3 | 5.4 | 620 |
| memory impairmentSignal | 74 | 5.8 | 4.7 | 294 |
| anxietySignal | 151 | 5.8 | 4.9 | 596 |
| fatigueSignal | 299 | 4.2 | 3.8 | 743 |
| gait disturbanceSignal | 73 | 4.1 | 3.3 | 172 |
| depressionSignal | 86 | 4.1 | 3.3 | 201 |
| insomniaSignal | 69 | 2.8 | 2.2 | 80 |
| nausea | 79 | 1.1 | 0.9 | 0 |
| drug ineffective | 73 | 0.6 | 0.5 | 20 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.